The data sharing deal will allow the clinical artificial intelligence company to get access to three separate anonymised patient data sets in three specific disease areas, including cardiovascular disease.
The anonymised patient data will be used by Sensyne to undertake medical research using Clinical AI, improve pharmaceutical development and help deliver better patient care.
NHS Greater Glasgow and Clyde is the largest NHS organisation in Scotland and one of the largest in the UK, including 35 hospitals of different types, serving a population of 1.14mln and employing 39,000 staff.
The agreement falls under the Glasgow Safe Haven partnership between NHS Greater Glasgow and Clyde and the University of Glasgow, designed to provide secure access to NHS and other health datasets derived from diverse sources across the health service.
The Glasgow Safe Haven is accredited by the Scottish Government as an accredited Safe Haven, and is one of four regional Safe Havens across Scotland.
By enabling researchers to link data from different sources, Safe Havens encourage data-driven health research to improve health services, design better treatments, and to create innovative new health products to support better health in Scotland.
“We are delighted to be working with one of the largest NHS Boards in Scotland on data analysis to improve patient care and accelerate medical research,” said chief executive Lord Drayson.
“Adding this data sharing agreement to our Strategic Research Agreements expands our access to anonymised patient data to now cover 3.9mln patients.”
Shares shot up 19% to 69p on Thursday afternoon.